| Bioactivity | A-800141 is an orally active and selective MetAP2 inhibitor with an IC50 of 12 nM. A-800141 has weak inhibitory activity for MetAP1 (IC50 : 36 μM). GAPDH can be used as a biomarker to monitor the MetAP2 inhibition of A-800141. A-800141 has antiangiogenic and anticancer activity in a variety of xenograft tumor models[1]. |
| CAS | 681245-85-2 |
| Formula | C24H30N2O4S |
| Molar Mass | 442.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang J, et al. Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor. Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):1838-43. |
A-800141
CAS: 681245-85-2 F: C24H30N2O4S W: 442.57
A-800141 is an orally active and selective MetAP2 inhibitor with an IC50 of 12 nM. A-800141 has weak inhibitory activity
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.